Key Events This Week
15 Jun: Golden Cross formation signals potential bullish breakout
16 Jun: Technical momentum shifts to bullish amid mixed market returns
19 Jun: Week closes at Rs.797.10, up 3.65% for the week
Jun 24, 03:30 PM
BSE+NSE Vol: 41.02 k

Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in its Mojo Grade to 'Sell' from 'Strong Sell', the stock’s price action and technical indicators reveal a cautiously optimistic outlook tempered by underlying weaknesses.
Read full news article
15 Jun: Golden Cross formation signals potential bullish breakout
16 Jun: Technical momentum shifts to bullish amid mixed market returns
19 Jun: Week closes at Rs.797.10, up 3.65% for the week

Astec Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend. Despite a modest day decline of 1.01%, the stock’s technical indicators reveal a complex interplay of signals that investors should carefully analyse amid broader market dynamics.
Read full news article
The 50-day moving average has crossed above the 200-day moving average for Astec Lifesciences Ltd, signalling a golden cross on 15 Jun 2026. Yet, the stock declined 1.01% on the same day, and the monthly technical indicators present a nuanced picture. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability.
Read full news article
1 June: Stock opens at Rs.770.85, drops 4.18% amid technical concerns
2 June: Intraday high of Rs.794.90 with 8.17% surge; Mojo Grade downgraded to Strong Sell
3 June: Mildly bullish momentum emerges with 6.65% gain closing at Rs.787.75
5 June: Week closes at Rs.755.80, down 3.05% on final trading day
8 June: Intraday high of Rs.779.90 with a 7.44% surge
9 June: Mojo Score upgraded to Sell from Strong Sell
10 June: Price correction with a 2.00% decline
12 June: Week closes at Rs.769.00, up 1.75% for the week

Astec Lifesciences Ltd, a small-cap player in the Pesticides & Agrochemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 8 June 2026. This change reflects a nuanced shift in the company’s technical outlook amid persistent fundamental weaknesses, prompting a reassessment of its risk and return profile by analysts at MarketsMOJO.
Read full news article
The Sensex declined by 0.85% on 8 Jun 2026, while Astec Lifesciences Ltd surged 7.44%, outperforming its sector by 4.17 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read full news articlePlease find enclosed intimation.
Please find enclosed Newspaper publication.
Please find enclosed intimation regarding Postal Ballot notice.
No Upcoming Board Meetings
Astec Lifesciences Ltd has declared 15% dividend, ex-date: 21 Jul 23
No Splits history available
No Bonus history available
Astec Lifesciences Ltd has announced 1:7 rights issue, ex-date: 04 Jul 25